Репродуктивные нарушения и акушерские осложнения при гинекологических заболеваниях

Обложка

Цитировать

Полный текст

Аннотация

Настоящая публикация отражает существующие риски акушерских осложнений и других репродуктивных нарушений у женщин с гинекологическими заболеваниями. В работе также рассматриваются вопросы прегравидарной подготовки женщин с гинекологическими заболеваниями с особым акцентом на применение дипиридамола ввиду его плейотропного действия.

Об авторах

Ара Леонидович Унанян

ФГАОУ ВО «Первый МГМУ им. И.М.Сеченова»

Email: 9603526@mail.ru
д-р мед. наук, проф. каф. акушерства и гинекологии №1 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

Ираида Степановна Сидорова

ФГАОУ ВО «Первый МГМУ им. И.М.Сеченова»

Email: 9603526@mail.ru

акад. РАН, д-р мед. наук, проф. каф. акушерства и гинекологии №1

119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

Анастасия Дмитриевна Никонец

ФГАОУ ВО «Первый МГМУ им. И.М.Сеченова»

Email: 9603526@mail.ru

студентка, Центр инновационных образовательных программ «Медицина будущего»

119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

Лиана Назимовна Аминова

КБ №2 МЕДСИ по гинекологии

Email: 9603526@mail.ru

канд. мед. наук, гл. спец. , зав. отд-нием гинекологии

125284, Russian Federation, Moscow, 2-i Botkinskii pr., d. 5

Владимир Александрович Алимов

КБ №2 МЕДСИ по гинекологии

Email: 9603526@mail.ru

акушер-гинеколог отд-ния гинекологии

125284, Russian Federation, Moscow, 2-i Botkinskii pr., d. 5

Анастасия Викторовна Щукина

ГБУЗ ГП №68

Email: 9603526@mail.ru

зав. женской консультацией

119180, Russian Federation, Moscow, ul. Malaya Yakimanka, d. 22, str. 1

Юрий Васильевич Чушков

ФГАОУ ВО «Первый МГМУ им. И.М.Сеченова»

Email: 9603526@mail.ru

канд. мед. наук, доц. каф. акушерства и гинекологии №1

119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

Дмитрий Валерьевич Бабурин

ФГАОУ ВО «Первый МГМУ им. И.М.Сеченова»

Автор, ответственный за переписку.
Email: 9603526@mail.ru

ассистент каф. акушерства и гинекологии №1

119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

Список литературы

  1. Vannuccini S, Clifton V.L, Fraser I.S et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update 2016; 22 (1): 104-15.
  2. Johnson N.P, Hummelshoj L. World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Hum Reprod 2013; 28 (6): 1552-68.
  3. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand 2016. doi: 10.1111/aogs.13082
  4. Dunselman G.A, Vermeulen N, Becker C et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29 (3): 400-12.
  5. Jacobson T.Z, Duffy J.M, Barlow D et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2010: CD001398.
  6. Duffy J.M, Arambage K, Correa F.J et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 2014: CD011031.
  7. Singh S.S, Suen M.W. Surgery for endometriosis: beyond medical therapies. Fertil Steril 2017; 107 (3): 549-4.
  8. Goodman L.R, Goldberg J.M, Flyckt R.L et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol 2016; 215 (589): e1-6.
  9. Hamdan M, Dunselman G, Li T.C, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update 2015; 21: 809-25.
  10. Vercellini P, Somigliana E, Vigano P et al. The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review. Acta Obstet Gynecol Scand 2009; 88: 1074-82.
  11. Dunselman G.A, Vermeulen N, Becker C et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29 (3): 400-12.
  12. Hughes E, Brown J, Collins J.J et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007: CD000155.
  13. Sallam H.N, Garcia-Velasco J.A, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006; 1: CD004635.
  14. Takemura Y, Osuga Y, Fujimoto A et al. Increased risk of placenta previa is associated with endometriosis and tubal factor infertility in assisted reproductive technology pregnancy. Gynecol Endocrinol 2013; 29: 113-5.
  15. Vercellini P, Parazzini F, Pietropaolo G et al. Pregnancy outcome in women with peritoneal, ovarian and rectovaginal endometriosis: a retrospective cohort study. BJOG 2012; 119: 1538-43.
  16. Conti N, Cevenini G, Vannuccini S et al. Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome. J Matern Fetal Neonatal Med 2014; 9: 1-4.
  17. Fernando S, Breheny S, Jaques A.M et al. Preterm birth, ovarian endometrioma, and assisted reproduction technologies. Fertil Steril 2009; 91: 325-30.
  18. Leone Roberti Maggiore U, Ferrero S, Mangili G et al. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update 2016; 22 (1): 70-103.
  19. Aris A. A 12-year cohort study on adverse pregnancy outcomes in Eastern Townships of Canada: impact of endometriosis. Gynecol Endocrinol 2014; 30: 34-7.
  20. Hashimoto A, Iriyama T, Sayama S et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. J Matern Fetal Neonatal Med 2017 Feb 9; p. 1-6.
  21. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update 2012; 18 (4): 374-92.
  22. Vigano P, Corti L, Berlanda N. Beyond infertility: obstetrical and postpartum complications associated with endometriosis and adenomyosis. Fertil Steril 2015; 104 (4): 802-12.
  23. Takebayashi A, Kimura F, Kishi Y. The association between endometriosis and chronic endometritis. PLoS One 2014; 9 (2): e88354.
  24. McQueen D.B, Bernardi L.A, Stephenson M.D. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril 2014; 101 (4): 1026-30.
  25. Cicinelli E, Matteo M, Tinelli R. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod 2015; 30 (2): 323-30.
  26. Yang R, Du X, Wang Y et al. The hysteroscopy and histological diagnosis and treatment value of chronic endometritis in recurrent implantation failure patients. Arch Gynecol Obstet 2014; 289: 1363-9.
  27. Радзинский В.Е., Киселев В.И., Муйжнек Е.Л. и др. Хронический эндометрит и фертильность: новые ответы. Терапевтические возможности преодоления хронического воспаления в эндометрии и улучшения фертильности: информационный бюллетень. М.: StatusPraesens, 2016.
  28. Balen A.H, Morley L.C, Misso M et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22 (6): 687-708.
  29. Goodman N.F et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - PART 2. Endocr Pract 2015; 21 (12): 1415-26.
  30. Yu H.F, Chen H.S, Rao D.P, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2016; 95 (51): e4863.
  31. Klevedal C, Turkmen S. Fetal-maternal outcomes and complications in pregnant women with polycystic ovary syndrome. Minerva Ginecol 2017; 69 (2): 141-9.
  32. Li Y.Y, Ye S.Q, Zhong Z.H et al. Associations between maternal BMI as well as glucose tolerance and adverse pregnancy outcomes in women with polycystic ovary syndrome. Gynecol Endocrinol 2017; 33 (4): 328-31.
  33. Klenov V.E, Jungheim E.S. Obesity and reproductive function: a review of the evidence. Curr Opin Obstet Gynecol 2014; 26: 455-60.
  34. Moran L. Weight management to improve outcomes in infertility. Transforming reproductive medicine worldwide. Birmingham: American Society for Reproductive Medicine, 2013; p. 66-73.
  35. Kort J.D, Winget C, Kim S.H, Lathi R.B. A retrospective cohort study to evaluate the impact of meaningful weight loss on fertility outcomes in an overweight population with infertility. Fertil Steril 2014; 101 (5): 1400-3.
  36. Garvey W.T, Mechanick J.I, Brett E.M et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Assosiation of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity. Edocr Pract 2016; Suppl 3: 1-203.
  37. Cornthwaite K, Jefferys A, Lenguerrand E et al. Pregnancy after weight loss surgery: a commentary. BJOG 2016; 123: 165-70.
  38. Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 2016; 12: CD002249.
  39. Franik S, Kremer J.A, Nelen W.L. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014; 2: CD010287.
  40. Legro R.S, Arslanian S.A, Ehrmann D.A. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98 (12): 4565-92.
  41. Conti N, Tosti C, Pinzauti S et al. Uterine fibroids affect pregnancy outcome in women over 30 years old: role of other risk factors. J Matern Fetal Neonatal Med 2013; 26: 584-7.
  42. Shavell V.I, Thakur M, Sawant A et al. Adverse obstetric outcomes associated with sonographically identified large uterine fibroids. Fertil Steril 2012; 97: 107-10.
  43. Lam S.J, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol 2014; 211: 395.
  44. Deveer M, Deveer R, Engin-Ustun Y et al. Comparison of pregnancy outcomes in different localizations of uterine fibroids. Clin Exp Obstet Gynecol 2012; 39: 516-8.
  45. Cheung A, Sierra S, Carranza-Mamane B et al. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can 2015; 37 (3): 277-85.
  46. Palmer J.E, Perunovic B, Tidy J.A. Endometrial hyperplasia. Obstet Gynaecologist 2008; 10: 211-6.
  47. Owens G.L, Kitchener H.C. Premalignant disease in the genital tract in pregnancy. Best Pract Res Clin Obstet Gynaecol 2016; 33: 33-43.
  48. Gunderson C.C, Fader A.N, Carson K.A, Bristow R.E. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol 2012; 125: 477-82.
  49. Poon L.C, Savvas M, Zamblera D et al. Large loop excision of transformation zone and cervical length in the prediction of spontaneous preterm delivery. BJOG: an international journal of obstetrics and gynaecology 2012; 119 (6): 692-8.
  50. Kyrgiou M, Mitra A, Arbyn M et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 2014; 349: g6192.
  51. Kyrgiou M, Athanasiou A, Paraskevaidi M et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ 2016; 354: i3633.
  52. Kindinger L.M, Kyrgiou M, MacIntyre D.A. Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage. PLoS One 2016; 11 (11): e0163793.
  53. Balakumar P, Nyo Y.H, Renushia R, Raaginey D. Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel? Pharmacol Res 2014; 87: 144-50.
  54. Van Hylckama Vlieg A, Helmerhorst F.M, Vandenbroucke J.P et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339: b2921.
  55. Okoroh E.M, Hooper W.C., Atrash H.K et al. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol 2012; 207 (5), 377: e1-8.
  56. Okoroh E.M, Boulet S.L, George M.G et al. Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome. Thromb Res 2015; 136 (6): 1165-8.
  57. Sugiura K, Kobayashi T, Ojima T. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women. Thromb Res 2016; 137: 11-6.
  58. Yamanaka A, Kimura F, Yoshida T et al. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia. Eur J Obstet Gynecol Reprod Biol 2016; 204: 99-103. doi: 10.1016/j.ejogrb.2016.07.499
  59. Eisert W.G. Dipyridamole in antithrombotic treatment. Adv Cardiol 2012; 47: 78-86.
  60. Santanam N, Kavtaradze N, Murphy A et al. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Transl Res 2013; 161 (3): 189-95. doi: 10.1016/j.trsl.2012.05.001
  61. Ciacciarelli M, Zerbinati C, Violi F, Iuliano L. Dipyridamole: a drug with unrecognized antioxidant activity. Curr Top Med Chem 2015; 15 (9): 822-9.
  62. Сидорова И.С., Леваков С.А., Унанян А.Л. Комплексная консервативная терапия миомы матки в сочетании с аденомиозом: применение препарата «Курантил®». Consilium Medicum. 2007; 9 (6): 21-4.
  63. Сидорова И.С., Унанян А.Л., Власов Р.С. Роль антиагрегантной терапии в лечении хронического эндометрита. Гинекология. 2009; 11 (4): 33-6
  64. Унанян А.Л., Аракелов С.Э., Полонская Л.С. и др. Плацентарная недостаточность: особенности этиопатогенеза, терапии и профилактики. Consilium Medicum. 2015; 17 (6): 37-40.
  65. Kelly R, Holzman C, Senagore P et al. Placental vascular pathology findings and pathways of preterm delivery. Am J Epidemiol 2009; 170: 148-58.
  66. Van Vliet E.O, Askie L.A, Mol B.W, Oudijk M.A. Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis. Obstet Gynecol 2017; 129 (2): 327-36.
  67. Duley L, Henderson-Smart D.J, Meher S, King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; 2: CD004659.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО "Консилиум Медикум", 2018

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).